Cargando…

A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors

The accurate detection of disease-related biomarkers is crucial for the early diagnosis and management of disease in personalized medicine. Here, we present a molecular imaging of human epidermal growth factor receptor (EGFR)-expressing malignant tumors using an EGFR-specific repebody composed of le...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Misun, Kim, Dong-Yeon, Lee, Joong-jae, Kim, Hyeon-Sik, Kim, Hyung-Seok, Pyo, Ayoung, Ryu, Yiseul, Kim, Tae-Yoon, Zheng, Jin Hai, Yoo, Su Woong, Hyun, Hoon, Oh, Gyungseok, Jeong, Jaeho, Moon, Myeongju, Min, Jung-Hyun, Kwon, Seong Young, Kim, Jung Young, Chung, Euiheon, Hong, Yeongjin, Lee, Wansik, Kim, Hak-Sung, Min, Jung-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558557/
https://www.ncbi.nlm.nih.gov/pubmed/28819451
http://dx.doi.org/10.7150/thno.18096
_version_ 1783257405351526400
author Yun, Misun
Kim, Dong-Yeon
Lee, Joong-jae
Kim, Hyeon-Sik
Kim, Hyung-Seok
Pyo, Ayoung
Ryu, Yiseul
Kim, Tae-Yoon
Zheng, Jin Hai
Yoo, Su Woong
Hyun, Hoon
Oh, Gyungseok
Jeong, Jaeho
Moon, Myeongju
Min, Jung-Hyun
Kwon, Seong Young
Kim, Jung Young
Chung, Euiheon
Hong, Yeongjin
Lee, Wansik
Kim, Hak-Sung
Min, Jung-Joon
author_facet Yun, Misun
Kim, Dong-Yeon
Lee, Joong-jae
Kim, Hyeon-Sik
Kim, Hyung-Seok
Pyo, Ayoung
Ryu, Yiseul
Kim, Tae-Yoon
Zheng, Jin Hai
Yoo, Su Woong
Hyun, Hoon
Oh, Gyungseok
Jeong, Jaeho
Moon, Myeongju
Min, Jung-Hyun
Kwon, Seong Young
Kim, Jung Young
Chung, Euiheon
Hong, Yeongjin
Lee, Wansik
Kim, Hak-Sung
Min, Jung-Joon
author_sort Yun, Misun
collection PubMed
description The accurate detection of disease-related biomarkers is crucial for the early diagnosis and management of disease in personalized medicine. Here, we present a molecular imaging of human epidermal growth factor receptor (EGFR)-expressing malignant tumors using an EGFR-specific repebody composed of leucine-rich repeat (LRR) modules. The repebody was labeled with either a fluorescent dye or radioisotope, and used for imaging of EGFR-expressing malignant tumors using an optical method and positron emission tomography. Our approach enabled visualization of the status of EGFR expression, allowing quantitative evaluation in whole tumors, which correlated well with the EGFR expression levels in mouse or patients-derived colon cancers. The present approach can be effectively used for the accurate detection of EGFR-expressing cancers, assisting in the development of a tool for detecting other disease biomarkers.
format Online
Article
Text
id pubmed-5558557
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-55585572017-08-17 A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors Yun, Misun Kim, Dong-Yeon Lee, Joong-jae Kim, Hyeon-Sik Kim, Hyung-Seok Pyo, Ayoung Ryu, Yiseul Kim, Tae-Yoon Zheng, Jin Hai Yoo, Su Woong Hyun, Hoon Oh, Gyungseok Jeong, Jaeho Moon, Myeongju Min, Jung-Hyun Kwon, Seong Young Kim, Jung Young Chung, Euiheon Hong, Yeongjin Lee, Wansik Kim, Hak-Sung Min, Jung-Joon Theranostics Research Paper The accurate detection of disease-related biomarkers is crucial for the early diagnosis and management of disease in personalized medicine. Here, we present a molecular imaging of human epidermal growth factor receptor (EGFR)-expressing malignant tumors using an EGFR-specific repebody composed of leucine-rich repeat (LRR) modules. The repebody was labeled with either a fluorescent dye or radioisotope, and used for imaging of EGFR-expressing malignant tumors using an optical method and positron emission tomography. Our approach enabled visualization of the status of EGFR expression, allowing quantitative evaluation in whole tumors, which correlated well with the EGFR expression levels in mouse or patients-derived colon cancers. The present approach can be effectively used for the accurate detection of EGFR-expressing cancers, assisting in the development of a tool for detecting other disease biomarkers. Ivyspring International Publisher 2017-06-25 /pmc/articles/PMC5558557/ /pubmed/28819451 http://dx.doi.org/10.7150/thno.18096 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Yun, Misun
Kim, Dong-Yeon
Lee, Joong-jae
Kim, Hyeon-Sik
Kim, Hyung-Seok
Pyo, Ayoung
Ryu, Yiseul
Kim, Tae-Yoon
Zheng, Jin Hai
Yoo, Su Woong
Hyun, Hoon
Oh, Gyungseok
Jeong, Jaeho
Moon, Myeongju
Min, Jung-Hyun
Kwon, Seong Young
Kim, Jung Young
Chung, Euiheon
Hong, Yeongjin
Lee, Wansik
Kim, Hak-Sung
Min, Jung-Joon
A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors
title A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors
title_full A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors
title_fullStr A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors
title_full_unstemmed A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors
title_short A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors
title_sort high-affinity repebody for molecular imaging of egfr-expressing malignant tumors
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558557/
https://www.ncbi.nlm.nih.gov/pubmed/28819451
http://dx.doi.org/10.7150/thno.18096
work_keys_str_mv AT yunmisun ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kimdongyeon ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT leejoongjae ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kimhyeonsik ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kimhyungseok ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT pyoayoung ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT ryuyiseul ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kimtaeyoon ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT zhengjinhai ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT yoosuwoong ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT hyunhoon ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT ohgyungseok ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT jeongjaeho ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT moonmyeongju ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT minjunghyun ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kwonseongyoung ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kimjungyoung ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT chungeuiheon ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT hongyeongjin ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT leewansik ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kimhaksung ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT minjungjoon ahighaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT yunmisun highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kimdongyeon highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT leejoongjae highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kimhyeonsik highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kimhyungseok highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT pyoayoung highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT ryuyiseul highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kimtaeyoon highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT zhengjinhai highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT yoosuwoong highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT hyunhoon highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT ohgyungseok highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT jeongjaeho highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT moonmyeongju highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT minjunghyun highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kwonseongyoung highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kimjungyoung highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT chungeuiheon highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT hongyeongjin highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT leewansik highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT kimhaksung highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors
AT minjungjoon highaffinityrepebodyformolecularimagingofegfrexpressingmalignanttumors